申请人:Laboratoires UPSA
公开号:US05358950A1
公开(公告)日:1994-10-25
The present invention relates to the derivatives of formula: ##STR1## and to their tautomeric forms as well as to their addition salts and to their use in therapy, in particular for the treatment of cardiovascular diseases, especially for the treatment of hypertension, cardiac insufficiency and diseases of the arterial wall.
本发明涉及以下式的衍生物:##STR1## 以及它们的互变异构体,以及它们的加合盐,以及它们在治疗中的应用,特别是用于治疗心血管疾病,尤其是用于治疗高血压、心脏衰竭和动脉壁疾病。